iBio, Inc. 8-K

What Happened

• iBio, Inc. (IBIO) filed an 8‑K on July 17, 2026 announcing its 2026 Annual Meeting of Stockholders is scheduled for October 14, 2026, and that the record date for voting will be the close of business on September 1, 2026.
• Because the meeting date is earlier than prior-announced timelines (more than 30 days before the anniversary of the 2025 meeting), the company set new deadlines for shareholder proposals and nominations under relevant SEC rules and its bylaws.

Key Details

• Meeting date: October 14, 2026; Record date for voting: September 1, 2026.
• Deadline to submit Rule 14a-8 shareholder proposals for inclusion in iBio’s proxy materials: August 1, 2026. Proposals must meet Rule 14a-8 requirements and be delivered with all required documentation by that date.
• Deadline to submit proposals a shareholder intends to present at the meeting (but not seeking inclusion in the proxy statement) under the company’s bylaws: July 27, 2026 (10 days after this Form 8‑K disclosure).
• Deadline to comply with universal proxy Rule 14a-19 (for shareholders soliciting proxies for director nominees other than the company’s nominees): August 15, 2026 (60 days before the meeting). Public adjournment/postponement will not extend the Rule 14a-8 submission period.

Why It Matters

• These dates determine which shareholders can vote (record date) and which proposals or director nominees can appear in iBio’s proxy materials or be presented at the meeting. Retail investors and activist shareholders should note the firm deadlines (Aug 1, July 27, Aug 15) and ensure submissions meet SEC Rule 14a-8, Rule 14a-19 and iBio’s bylaw requirements to be considered.